Scalp Care and Hair Transplant Recovery Study
Part of Skin clinical trials.
This study looks at how to keep your scalp healthy after a hair transplant procedure. Researchers will test scalp management protocols to help your transplanted hair grow well and reduce dandruff-like scalp issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male between 18 and 55 years old
- You have male pattern baldness (hair loss on top or back of head) rated Grade II to VI
- You are scheduled for or have recently had hair transplant surgery, with a doctor confirming your scalp is suitable for the study
- You have no or only mild dandruff-like scalp condition (seborrheic dermatitis)
- You haven't used anti-dandruff shampoo in the past 2 weeks or had hair treatments (dyeing, perming, styling products) in the past month
- You can attend all study visits and complete questionnaires on time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new lotion for people with mild to moderate seborrheic dermatitis (a common skin condition causing red, scaly patches on the scalp, face, or chest). The study checks safety and how well the lotion works.
This study tests a new antidandruff lotion designed to restore the natural balance of microbes on your scalp. If you have moderate to severe dandruff and are generally healthy, this trial may help improve your dandruff with a specially formulated product.
This trial tests if special hair follicles can be used for cell replacement therapy in disease. It may help people with certain medical conditions.
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
This trial tests a scalp cooling cap to see if it can prevent hair loss in women receiving certain targeted chemo infusions (antibody-drug conjugates) for advanced solid tumours. If it works, you may keep more of your hair during treatment.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
Hear when a new Seborrheic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.